Bionano Genomics, Inc. (BNGO)
USD 0.21
(-0.47%)
USD 0.21
(-0.47%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -213.6 Million USD | 3.6% |
| 2022 | -120.31 Million USD | -69.54% |
| 2021 | -73.85 Million USD | -99.54% |
| 2020 | -37.08 Million USD | -48.99% |
| 2019 | -26.37 Million USD | -22.68% |
| 2018 | -15.77 Million USD | 1.44% |
| 2017 | -21.25 Million USD | -5.64% |
| 2016 | -17.25 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -17.24 Million USD | 55.01% |
| 2024 Q1 | -24.07 Million USD | 20.24% |
| 2023 Q3 | -31.5 Million USD | 11.16% |
| 2023 FY | - USD | 3.6% |
| 2023 Q4 | -16.43 Million USD | 47.82% |
| 2023 Q1 | -37.02 Million USD | -0.61% |
| 2023 Q2 | -35.45 Million USD | 4.23% |
| 2022 Q4 | -36.79 Million USD | -25.69% |
| 2022 Q1 | -27.62 Million USD | 3.1% |
| 2022 Q3 | -29.27 Million USD | 1.39% |
| 2022 FY | - USD | -69.54% |
| 2022 Q2 | -29.69 Million USD | -7.47% |
| 2021 Q3 | -20.15 Million USD | -26.15% |
| 2021 Q4 | -28.51 Million USD | -41.47% |
| 2021 FY | - USD | -99.54% |
| 2021 Q1 | -10.73 Million USD | 3.57% |
| 2021 Q2 | -15.97 Million USD | -48.88% |
| 2020 FY | - USD | -48.99% |
| 2020 Q1 | -9.44 Million USD | -31.95% |
| 2020 Q2 | -7.21 Million USD | 23.66% |
| 2020 Q3 | -9.85 Million USD | -36.63% |
| 2020 Q4 | -11.12 Million USD | -12.91% |
| 2019 FY | - USD | -22.68% |
| 2019 Q4 | -7.16 Million USD | -29.31% |
| 2019 Q3 | -5.53 Million USD | 18.89% |
| 2019 Q2 | -6.82 Million USD | -6.95% |
| 2019 Q1 | -6.38 Million USD | -4.04% |
| 2018 Q1 | -4.1 Million USD | 3.66% |
| 2018 Q2 | -3.68 Million USD | 10.15% |
| 2018 FY | - USD | 1.44% |
| 2018 Q3 | -5.65 Million USD | -53.35% |
| 2018 Q4 | -6.13 Million USD | -8.52% |
| 2017 FY | - USD | -5.64% |
| 2017 Q1 | -5.85 Million USD | 0.0% |
| 2017 Q2 | -6.42 Million USD | -9.71% |
| 2017 Q3 | -4.85 Million USD | 24.37% |
| 2017 Q4 | -4.25 Million USD | 12.34% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Prenetics Global Limited | -47.89 Million USD | -345.974% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -12561.766% |
| CareDx, Inc | -89.65 Million USD | -138.246% |
| Exact Sciences Corporation | 41.87 Million USD | 610.087% |
| Exagen Inc. | -19.15 Million USD | -1015.251% |
| Inotiv, Inc. | -26.5 Million USD | -705.87% |
| Guardant Health, Inc. | -433.3 Million USD | 50.704% |
| Biodesix, Inc. | -37.1 Million USD | -475.705% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -8495.178% |
| Precipio, Inc. | -4.31 Million USD | -4846.827% |
| iSpecimen Inc. | -9.1 Million USD | -2246.338% |
| Natera, Inc. | -383.27 Million USD | 44.269% |
| Aspira Women's Health Inc. | -16.49 Million USD | -1195.276% |
| Standard BioTools Inc. | -54.45 Million USD | -292.243% |
| 23andMe Holding Co. | -291.87 Million USD | 26.816% |
| Castle Biosciences, Inc. | -45.02 Million USD | -374.423% |
| Personalis, Inc. | -96.8 Million USD | -120.649% |
| Aclaris Therapeutics, Inc. | -117.56 Million USD | -81.69% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | -2127.12% |
| OpGen, Inc. | -29.51 Million USD | -623.811% |
| T2 Biosystems, Inc. | -43.87 Million USD | -386.847% |
| Myriad Genetics, Inc. | -67.8 Million USD | -215.05% |
| ICON Public Limited Company | 1.63 Billion USD | 113.091% |
| NeoGenomics, Inc. | -17.6 Million USD | -1113.177% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -12561.766% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 117.542% |
| RadNet, Inc. | 292.78 Million USD | 172.956% |
| MDxHealth SA | -30.46 Million USD | -601.077% |
| Psychemedics Corporation | -251 Thousand USD | -85001.195% |
| Illumina, Inc. | -608 Million USD | 64.868% |
| Check-Cap Ltd. | -17.64 Million USD | -1110.29% |
| Twist Bioscience Corporation | -176.7 Million USD | -20.882% |
| DarioHealth Corp. | -53.49 Million USD | -299.305% |
| Fulgent Genetics, Inc. | -46.55 Million USD | -358.85% |
| Sera Prognostics, Inc. | -35.28 Million USD | -505.333% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | -2083.018% |
| OPKO Health, Inc. | -65.51 Million USD | -226.033% |
| Medpace Holdings, Inc. | 363.15 Million USD | 158.819% |
| Neogen Corporation | 182.59 Million USD | 216.981% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | -2324.368% |
| Prenetics Global Limited | -47.89 Million USD | -345.974% |
| Mainz Biomed B.V. | -25.01 Million USD | -754.033% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -2699.783% |
| Trinity Biotech plc | -24.09 Million USD | -786.397% |
| Neuronetics, Inc. | -22.75 Million USD | -838.547% |
| Sotera Health Company | 514.14 Million USD | 141.546% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -2699.783% |